Skip to content
10-K

Annual Report

DICE THERAPEUTICS, INC.

0000950170-23-008119

← back to feed
Filed
Mar 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 8, 2023 47.71M sh
Shares Diluted FY 2022 · Dec 31, 2022 39.4M sh
Shares Diluted FY 2022 · Dec 31, 2021 12.38M sh
Capex FY 2022 · Dec 31, 2022 $2.24M
Capex FY 2022 · Dec 31, 2021 $718K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$64.32M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$39.29M
Cash And Equivalents FY 2022 · Dec 31, 2022 $461.39M
Cash And Equivalents FY 2022 · Dec 31, 2021 $115.83M
Stockholders Equity FY 2022 · Dec 31, 2022 $566.99M
Stockholders Equity FY 2022 · Dec 31, 2021 $312.95M
Stockholders Equity FY 2022 · Dec 31, 2020 −$53.15M
Current Liabilities FY 2022 · Dec 31, 2022 $15.15M
Current Liabilities FY 2022 · Dec 31, 2021 $10.88M
Total Liabilities FY 2022 · Dec 31, 2022 $26.99M
Total Liabilities FY 2022 · Dec 31, 2021 $12.81M
Current Assets FY 2022 · Dec 31, 2022 $577.76M
Current Assets FY 2022 · Dec 31, 2021 $323.91M
Total Assets FY 2022 · Dec 31, 2022 $593.98M
Total Assets FY 2022 · Dec 31, 2021 $325.75M
Eps Diluted FY 2022 · Dec 31, 2022 −$2.13
Eps Diluted FY 2022 · Dec 31, 2021 −$3.95
Eps Basic FY 2022 · Dec 31, 2022 −$2.13
Eps Basic FY 2022 · Dec 31, 2021 −$3.95
Sga Expense FY 2022 · Dec 31, 2022 $25.66M
Sga Expense FY 2022 · Dec 31, 2021 $12.22M
Rd Expense FY 2022 · Dec 31, 2022 $62.56M
Rd Expense FY 2022 · Dec 31, 2021 $36.51M
Net Income FY 2022 · Dec 31, 2022 −$83.89M
Net Income FY 2022 · Dec 31, 2021 −$48.96M
Operating Income FY 2022 · Dec 31, 2022 −$88.22M
Operating Income FY 2022 · Dec 31, 2021 −$47.6M
Long Term Debt FY 2022 · Dec 31, 2021 $1.92M
Short Term Debt FY 2022 · Dec 31, 2021 $480K
Revenue FY 2022 · Dec 31, 2021 $1.13M